X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9) 9
oncology (9) 9
cancer (8) 8
aged (7) 7
female (7) 7
humans (7) 7
male (7) 7
middle aged (7) 7
adult (6) 6
chemotherapy (6) 6
colorectal cancer (5) 5
survival (5) 5
aged, 80 and over (4) 4
oxaliplatin (4) 4
patients (4) 4
radiation-therapy (4) 4
treatment outcome (4) 4
trial (4) 4
adenocarcinoma (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
brachytherapy (3) 3
fluorouracil (3) 3
gastroenterology and hepatology (3) 3
hematology, oncology and palliative medicine (3) 3
lung neoplasms - secondary (3) 3
mitomycin (3) 3
radiation therapy (3) 3
rectal cancer (3) 3
retrospective studies (3) 3
survival analysis (3) 3
toxicity (3) 3
tumors (3) 3
1st-line treatment (2) 2
analysis (2) 2
cancer therapies (2) 2
capecitabine (2) 2
care and treatment (2) 2
chemoradiation (2) 2
cisplatin (2) 2
cohort studies (2) 2
colorectal neoplasms - pathology (2) 2
colorectal-cancer (2) 2
combination chemotherapy (2) 2
combined modality therapy (2) 2
conservative treatment (2) 2
contact x-ray brachytherapy (2) 2
disease (2) 2
disease-free survival (2) 2
fluorouracil - administration & dosage (2) 2
france (2) 2
gastroenterology & hepatology (2) 2
gemcitabine (2) 2
intestine (2) 2
kaplan-meier estimate (2) 2
leucovorin - administration & dosage (2) 2
liver metastases (2) 2
liver neoplasms - secondary (2) 2
metastases (2) 2
metastasis (2) 2
mitomycin - administration & dosage (2) 2
organ preservation (2) 2
outcomes (2) 2
preservation (2) 2
prognosis (2) 2
radiotherapy (2) 2
rectum (2) 2
salvage (2) 2
sphincter (2) 2
surgery (2) 2
1st progression (1) 1
1st-line therapy (1) 1
2 randomized-trial (1) 1
3rd-line therapy (1) 1
5-fluorouracil (1) 1
5‐fluorouracil (1) 1
accuracy (1) 1
acute toxicity (1) 1
advanced colorectal cancer (1) 1
advanced gastric cancer (1) 1
alcohol (1) 1
alcoholism - diagnostic imaging (1) 1
alcoholism - metabolism (1) 1
anal canal (1) 1
anal canal - pathology (1) 1
anal cancer (1) 1
anal squamous cell carcinoma (1) 1
anorexia - chemically induced (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antimetabolites, antineoplastic - administration & dosage (1) 1
antimetabolites, antineoplastic - adverse effects (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
anus (1) 1
anus neoplasms - pathology (1) 1
anus neoplasms - therapy (1) 1
apoptosis (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4_suppl, pp. 149 - 149
149 Background: There is no therapeutic consensus after failure of two drug lines for metastatic gastric adenocarcinoma. The theoretical benefit of a... 
Journal Article
Journal Article
Cancer Medicine, ISSN 2045-7634, 11/2019, Volume 8, Issue 16, pp. 6853 - 6859
Background Metastatic squamous cell carcinomas (SCC) of the anal canal are rare and there is no international consensus on their second‐line management.... 
anal canal | 5‐fluorouracil | cancer | metastasis | chemotherapy | mitomycin | Squamous cell carcinoma | Mitomycin | Toxicity | Canals | Colorectal cancer | Clinical trials | Metastasis | Radiation therapy | Patients | Cancer therapies | Metastases | Proteins | Chemotherapy | Platinum | Response rates | Conflicts of interest | Ligands | Apoptosis | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4_suppl, pp. 497 - 497
497 Background: Recent reports demonstrate prognostic and predictive impacts of the location of the primary tumor in metastatic colorectal cancer (mCRC). Our... 
Journal Article
European Journal of Cancer, ISSN 0959-8049, 04/2019, Volume 111, pp. 94 - 106
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. 4120 - 4120
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 4_suppl, pp. 751 - 751
751 Background: The Lyon R96-02 randomized trial has demonstrated in T2-3 rectal cancer that external beam radiotherapy (EBRT) with Contact X Ray brachytherapy... 
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 02/2017, Volume 72, p. 124
Background Contact X-ray brachytherapy (CXB) has been used at Centre Antoine Lacassagne since 2002 to increase the chance of conservative treatment (organ or... 
X rays | Preservation | Intestine | Colorectal cancer | Rectum | Brachytherapy | Radiation therapy | Sphincter | Patients | Background radiation | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 4_suppl, pp. 94 - 94
94 Background: Trastuzumab in combination with platinum-based chemotherapy is the standard first line regimen in HER2 positive advanced gastric cancer.... 
Journal Article
Journal of Chemotherapy, ISSN 1120-009X, 08/2012, Volume 24, Issue 4, pp. 207 - 211
We investigated the efficacy and safety of oral Uracil/tegafur (UFT) with leucovorin and mitomycin C (MMC) as third-line treatment for patients with... 
Third-line chemotherapy | UFT | Salvage | Mitomycin C | Advanced colorectal cancer | 1ST-LINE TREATMENT | PLUS IRINOTECAN | ORAL LEUCOVORIN | RANDOMIZED-TRIAL | 3RD-LINE THERAPY | OXALIPLATIN | FLUOROURACIL | SUPPORTIVE CARE | CETUXIMAB | ONCOLOGY | COMBINATION CHEMOTHERAPY | PHARMACOLOGY & PHARMACY | Leucovorin - administration & dosage | Lung Neoplasms - drug therapy | Salvage Therapy - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Leucovorin - adverse effects | Neoplasm Grading | Uracil - administration & dosage | Lung Neoplasms - secondary | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Mitomycin - adverse effects | Mitomycin - therapeutic use | Tegafur - adverse effects | Tegafur - therapeutic use | Liver Neoplasms - drug therapy | Uracil - therapeutic use | Asthenia - chemically induced | Uracil - adverse effects | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Tegafur - administration & dosage | Anorexia - chemically induced | Aged | Colorectal Neoplasms - pathology | Drug Monitoring | Mitomycin - administration & dosage | Drug Combinations
Journal Article
European journal of cancer (Oxford, England : 1990), 12/2018, Volume 108, p. 1
Neoadjuvant chemoradiotherapy (nCRT) and watch-and-wait policy as reported by Habr-Gama are references for organ preservation in rectal cancer. To increase the... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.